title: Inositolhexakisphosphate (InsP6): an antagonist of fibroblast growth factor receptor binding and activity.
abstract: Fibroblast growth factors (FGF), which have been implicated in tumor cell growth and angiogenesis, have biological activities that appear to be mediated by both heparinlike extracellular matrix sites and transmembrane tyrosine kinase receptor sites. In the present study, we demonstrated that inositolhexakisphosphate (InsP6) inhibits basic FGF (bFGF) binding to heparin. Our spectrofluorometric analyses demonstrated that InsP6 not only bound to bFGF, presumably within the bFGF heparin-binding domain, but also protected bFGF from degradation by trypsin. Also, InsP6 inhibited the cellular binding of bFGF and other fibroblast growth factor family members such as acidic FGF (aFGF) and K-FGF in a saturable and dose-dependent manner. Furthermore, concentrations as low as 100 microM InsP6 inhibited bFGF-induced DNA synthesis in AKR-2B fibroblasts, as well as the growth of bFGF- and K-FGF-transfected NIH/3T3 cells. Together, these results indicate that InsP6 may serve as a useful antagonist of FGF activity.
authors.affiliation: Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston 77030.
authors.forename: R S
authors.initials: RS
authors.lastname: Morrison
authors.forename: E
authors.initials: E
authors.lastname: Shi
authors.forename: M
authors.initials: M
authors.lastname: Kan
authors.forename: F
authors.initials: F
authors.lastname: Yamaguchi
authors.forename: W
authors.initials: W
authors.lastname: McKeehan
authors.forename: M
authors.initials: M
authors.lastname: Rudnicka-Nawrot
authors.forename: K
authors.initials: K
authors.lastname: Palczewski
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry / Q000378:metabolism*; D005347:Fibroblasts / Q000737:chemistry / Q000166:cytology / Q000187:drug effects; D006493:Heparin / Q000378:metabolism*; D007457:Iodine Radioisotopes; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology; D051379:Mice; D010833:Phytic Acid / Q000494:pharmacology*; D017468:Receptors, Fibroblast Growth Factor / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D014407:Tumor Cells, Cultured
chemical_list: D007457:Iodine Radioisotopes; D017468:Receptors, Fibroblast Growth Factor; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D010833:Phytic Acid; D006493:Heparin